ExcellGene
Pre-clinicalExcellGene provides contract development and manufacturing services for mammalian cell-based biopharmaceutical production.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $17.5M
About
ExcellGene provides contract development and manufacturing services for mammalian cell-based biopharmaceutical production.
AntibodiesBiosimilarsViral Technology
Funding History
2Total raised:$17.5M
Series A$15MJun 15, 2021
Grant$2.5MMar 15, 2020